Saudi Arabia’s Food and Drug Agency (SFDA) said that it had approved the registration of the COVID-19 vaccine developed by the U.S.’ Pfizer and Germany’s BioNTech pharmaceutical companies for use in the country.
The agency said this in a statement, as cited by the official of Saudi Press Agency.
“Following thorough discussion of all technical and scientific parameters, it was decided to authorise the registration of the vaccine by Pfizer and BioNTech and its use,” the agency said.
The timeframe for the deliveries of the vaccine will be announced later, the SFDA added.
In November, the authorities said that the vaccination would be free of charge for all citizens of the kingdom and is projected to start in late 2020 or early 2021. (Sputnik/NAN)
